Beijing Tiantan Biological Products Corp Ltd (600161) — Cash Flow Reinvestment Rate
Beijing Tiantan Biological Products Corp Ltd (600161) has a Cash Flow Reinvestment Rate of 0.39x as of September 2025, reinvesting CN¥125.07 Million (capex CN¥125.07 Million ) from operating cash flow of CN¥318.80 Million. Check 600161 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Beijing Tiantan Biological Products Corp Ltd Cash Flow Reinvestment Rate (1998–2024)
Historical reinvestment intensity for Beijing Tiantan Biological Products Corp Ltd across 27 annual periods. Explore Beijing Tiantan Biological Products Corp long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Beijing Tiantan Biological Products Corp Ltd (1998–2024)
Year-by-year capital reinvestment analysis for Beijing Tiantan Biological Products Corp Ltd. For live market cap and broader valuation context, see 600161 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.36x | CN¥1.11 Billion | CN¥819.78 Million | CN¥1.07 Billion | ▲ +29.8% |
| 2023 | 1.05x | CN¥2.51 Billion | CN¥2.39 Billion | CN¥1.08 Billion | ▼ -63.4% |
| 2022 | 2.86x | CN¥3.22 Billion | CN¥1.13 Billion | CN¥1.35 Billion | ▲ +29.9% |
| 2021 | 2.21x | CN¥2.16 Billion | CN¥980.35 Million | CN¥1.13 Billion | ▲ +149.7% |
| 2020 | 0.88x | CN¥619.92 Million | CN¥702.11 Million | CN¥608.91 Million | ▲ +2.9% |
| 2019 | 0.86x | CN¥551.23 Million | CN¥642.47 Million | CN¥526.23 Million | ▲ +79.6% |
| 2018 | 0.48x | CN¥323.90 Million | CN¥677.92 Million | CN¥293.90 Million | ▼ -39.6% |
| 2017 | 0.79x | CN¥172.87 Million | CN¥218.39 Million | CN¥144.87 Million | ▲ +42.8% |
| 2016 | 0.55x | CN¥237.39 Million | CN¥428.37 Million | CN¥209.39 Million | ▼ -20.2% |
| 2015 | 0.69x | CN¥328.57 Million | CN¥473.26 Million | CN¥300.57 Million | ▼ -28.5% |
| 2014 | 0.97x | CN¥464.16 Million | CN¥477.95 Million | CN¥464.16 Million | ▲ +0.3% |
| 2013 | 0.97x | CN¥548.37 Million | CN¥566.43 Million | CN¥548.37 Million | ▼ -25.0% |
| 2012 | 1.29x | CN¥557.87 Million | CN¥432.00 Million | CN¥557.87 Million | ▼ -36.5% |
| 2011 | 2.04x | CN¥718.67 Million | CN¥353.15 Million | CN¥718.67 Million | ▲ +26.4% |
| 2010 | 1.61x | CN¥297.54 Million | CN¥184.85 Million | CN¥297.54 Million | ▲ +277.4% |
| 2009 | 0.43x | CN¥191.17 Million | CN¥448.23 Million | CN¥191.17 Million | ▼ -21.6% |
| 2008 | 0.54x | CN¥150.31 Million | CN¥276.39 Million | CN¥150.31 Million | ▲ +25.8% |
| 2007 | 0.43x | CN¥66.40 Million | CN¥153.55 Million | CN¥66.40 Million | ▼ -6.6% |
| 2006 | 0.46x | CN¥71.50 Million | CN¥154.36 Million | CN¥71.50 Million | ▲ +53.3% |
| 2005 | 0.30x | CN¥39.78 Million | CN¥131.69 Million | CN¥39.78 Million | ▼ -61.3% |
| 2004 | 0.78x | CN¥85.89 Million | CN¥110.11 Million | CN¥85.89 Million | ▼ -45.5% |
| 2003 | 1.43x | CN¥90.02 Million | CN¥62.93 Million | CN¥90.02 Million | ▲ +246.6% |
| 2002 | 0.41x | CN¥34.83 Million | CN¥84.38 Million | CN¥34.83 Million | ▼ -60.9% |
| 2001 | 1.06x | CN¥49.09 Million | CN¥46.49 Million | CN¥49.09 Million | ▲ +14.9% |
| 2000 | 0.92x | CN¥44.04 Million | CN¥47.90 Million | CN¥44.04 Million | ▼ -9.7% |
| 1999 | 1.02x | CN¥43.34 Million | CN¥42.58 Million | CN¥43.34 Million | ▼ -58.1% |
| 1998 | 2.43x | CN¥57.61 Million | CN¥23.71 Million | CN¥57.61 Million | — |